LeonaBio LONA
NASDAQ LONA
$4.02 -0.45 (-10.07%)
At close: Nov 10, 2026 · 4:00 PM EST

LeonaBio (LONA) Other Non-Current Liabilities (2019 - 2026)

Updated

LeonaBio (LONA) reported Other Non-Current Liabilities of $1.03 million for Q2 2026, down 15.3% from the prior quarter.

Analysis

LeonaBio (LONA) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, LeonaBio posted Other Non-Current Liabilities of $1.4 million.

  • The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Liabilities since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 LeonaBio 95.38 Mn -136.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.03 Mn
Mar 31, 2026 1.22 Mn
Dec 31, 2025 1.40 Mn
Dec 31, 2021 804,000.00
Dec 31, 2020 106,000.00
Dec 31, 2019 999,000.00
API Access

LeonaBio Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=LONA&period=max&api_key=YOUR_API_KEY